Sunday, October 19, 2008

Abbott Cornering Carcinogen Market?

Is reducing the signs and symptoms of rheumatoid arthritis and/or Crohn's Disease worth the risk of cancer and/or heart disease?

Abbott Laboratories seems to think so, as they are continually marketing a drug called Humira on TV. In the ad (like most prescription drug ads) you see people enjoying life, happy as clams because they found the wonder drug that has helped with their ailment.

And, these people continue to smile as if they have no care in the world, as the announcer reads off the side effects associated with taking Humira -- which include "certain types of cancer" (lymphoma) and "new" heart failure -- so if you had no signs of heart failure in the past, taking Humira can lead to it.

Why don't they just market this as a suicide drug? Humira, or other drugs like it known as TMF blockers, have actually caused cancer or heart disease in people who have taken them in the past. So, how does the FDA approve carcinogens like this? Isn't there a better way to treat victims of disease without introducing the possibility of more deadly diseases? It's like injecting people with the bubonic plague to cure dandruff.

And, how did Abbott Labs pull the wool over the eyes of the FDA to get this drug approved -- unless it was the wool that makes up the millions of dollars in U.S. currency that they flashed in front of them to get the okay.

Maybe it's just me, but I'd rather not take medicine that has the potential to kill me. I think most Americans would agree, and the FDA needs to start considering the interest of the general public when deciding to grant licenses for "cures" like Humira.

RoadRage

No comments: